.Attributes Medication, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspective asks for inclusion of clients along with MASLD and also size of liver end results in cardio-- renal-- metabolic trials, when data suggest mechanistically possible benefits and also scientific protection-- as well as outlines considerations for trial design and also governing commendation.